[1] ALEIDI SM, ALNEHMI EA, ALSHAKER M, et al. A distinctive human metabolomics alteration associated with osteopenic and osteoporotic patients. Metabolites. 2021;11(9):628-641.
[2] ZHU X, CHEN L, PAN L, et al. Risk factors of primary and recurrent fractures in postmenopausal osteoporotic Chinese patients: A retrospective analysis study. BMC Womens Health. 2022;22(1):465-477.
[3] 彭科军, 余三峰, 彭濡博, 等. 老年骨质疏松患者骨代谢指标与维生素D和维生素K水平的相关性[J]. 中国临床保健杂志,2022, 25(4):496-499.
[4] CUI L, JACKSON M, WESSLER Z, et al. Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among women in China: A simulation projection model from 2020 to 2040. Arch Osteoporos. 2021;16(1):118-127.
[5] LIU J, CURTIS EM, COOPER C, et al. State of the art in osteoporosis risk assessment and treatment. J Endocrinol Invest. 2019;42(10):1149-1164.
[6] LIANG B, BURLEY G, LIN S, et al. Osteoporosis pathogenesis and treatment: Existing and emerging avenues. Cell Mol Biol Lett. 2022; 27(1):72-97.
[7] GAO Y, PATIL S, JIA J. The development of molecular biology of osteoporosis. Int J Mol Sci. 2021;22(15):8182-8204.
[8] 陈桂锋, 尚奇, 沈耿杨, 等. 从“肾主骨生髓”揭示骨质疏松症炎症微环境的中医理论基础[J]. 中华中医药杂志,2022,37(12):6906-6909.
[9] 李焱, 窦群立, 杨锋. “肾为封藏之本”理论与原发性骨质疏松症发病机制的研究[J]. 中国骨质疏松杂志,2021,27(9):1369-1372.
[10] 苏辉, 闫炳翰, 王若冲, 等. 补肾壮骨方干预去卵巢骨质疏松模型大鼠骨代谢及骨密度的变化[J]. 中国组织工程研究,2023,27(28): 4507-4512.
[11] 薛堃, 邢秋娟, 吴佶, 等. 益气化瘀补肾方联合抗阻运动治疗原发性骨质疏松症疗效研究[J]. 陕西中医,2022,43(3):321-324.
[12] 赵佳盛, 阮丹丹, 郁啸云, 等. 益气化瘀补肾方联合西药治疗肾虚血瘀型腰椎退行性骨关节炎伴骨质疏松临床观察[J]. 辽宁中医杂志,2022,49(12):116-120.
[13] LIANG JW, LI PL, WANG Q, et al. Ferulic acid promotes bone defect repair after radiation by maintaining the stemness of skeletal stem cells. Stem Cells Transl Med. 2021;10(8):1217-1231.
[14] LU J, LI Z, WU X, et al. iRoot BP Plus promotes osteo/odontogenic differentiation of bone marrow mesenchymal stem cells via MAPK pathways and autophagy. Stem Cell Res Ther. 2019;10(1):222-235.
[15] NAKAMURA K, ASANUMA K, OKAMOTO T, et al. Combination of everolimus and bortezomib inhibits the growth and metastasis of bone and soft tissue sarcomas via JNK/p38/ERK MAPK and AKT pathways. Cancers. 2023;15(9):2468-2481.
[16] GREENBLATT MB, SHIM JH, BOK S, et al. The extracellular signal-regulated kinase mitogen-activated protein kinase pathway in osteoblasts. J Bone Metab. 2022;29(1):1-15.
[17] LI J, DU H, JI X, et al. ETV2 promotes osteogenic differentiation of human dental pulp stem cells through the ERK/MAPK and PI3K-Akt signaling pathways. Stem Cell Res Ther. 2022;13(1):495-508.
[18] PARK KR, LEE JY, CHO M, et al. Ziyuglycoside I upregulates RUNX2 through ERK1/2 in promoting osteoblast differentiation and bone mineralization. Am J Chin Med. 2021;49(4):883-900.
[19] GE C, CAWTHORN WP, LI Y, et al. Reciprocal control of osteogenic and adipogenic differentiation by ERK/MAP Kinase phosphorylation of Runx2 and PPARγ transcription factors. J Cell Physiol. 2016;231(3):587-596.
[20] KIM JM, YANG YS, PARK KH, et al. The ERK MAPK pathway is essential for skeletal development and homeostasis. Int J Mol Sci. 2019;20(8): 1803-1816.
[21] MATSUSHITA T, CHAN YY, KAWANAMI A, et al. Extracellular signal-regulated kinase 1 (ERK1) and ERK2 play essential roles in osteoblast differentiation and in supporting osteoclastogenesis. Mol Cell Biol. 2009;29(21):5843-5857.
[22] CHEN YH, CHUNG CC, LIU YC, et al. YY1 and HDAC9c transcriptionally regulate p38-mediated mesenchymal stem cell differentiation into osteoblasts. Am J Cancer Res. 2018;8(3):514-525.
[23] LI TL, LIU HD, REN MX, et al. Daytime administration of melatonin has better protective effects on bone loss in ovariectomized rats. J Orthop Surg Res. 2023;18(1):234-246.
[24] ZHANG X, CHEN Y, ZHANG C, et al. Effects of icariin on the fracture healing in young and old rats and its mechanism. Pharm Biol. 2021; 59(1):1245-1255.
[25] BATOON L, MILLARD SM, RAGGATT LJ, et al. Osteal macrophages support osteoclast-mediated resorption and contribute to bone pathology in a postmenopausal osteoporosis mouse model. J Bone Miner Res. 2021;36(11):2214-2228.
[26] YU K, HUANGFU H, QIN Q, et al. Application of bone marrow-derived macrophages combined with bone mesenchymal stem cells in dual-channel three-dimensional bioprinting scaffolds for early immune regulation and osteogenic induction in rat calvarial defects. ACS Appl Mater Interfaces. 2022;14(41):47052-47065.
[27] ZOU Z, LIU W, CAO L, et al. Advances in the occurrence and biotherapy of osteoporosis. Biochem Soc Trans. 2020;48(4):1623-1636.
[28] IANTOMASI T, ROMAGNOLI C, PALMINI G, et al. Oxidative stress and inflammation in osteoporosis: Molecular mechanisms involved and the relationship with microRNAs. Int J Mol Sci. 2023;24(4):3772-3789.
[29] SEQUETTO PL, GONÇALVES RV, PINTO AS, et al. Low doses of simvastatin potentiate the effect of sodium alendronate in inhibiting bone resorption and restore microstructural and mechanical bone properties in glucocorticoid-induced osteoporosis. Microsc Microanal. 2017;23(5):989-1001.
[30] 史馨钰, 任艳玲. 基于“命门学说”与“阴阳互济”探讨绝经后骨质疏松症的防治[J]. 中国医药导报,2019,16(25):110-113.
[31] 丁伟逸, 张霆, 林越, 等. 基于网络药理学探讨益气化瘀补肾方治疗骨延迟愈合的作用机制[J]. 实用中西医结合临床,2022,22(8): 7-13,24.
[32] 姚立彬, 李百占, 张立强, 等. 补肾益气化瘀汤治疗原发性骨质疏松症的临床疗效观察[J]. 中国药物与临床,2017,17(2):282-283.
[33] 史红逸, 赵赞, 林琳, 等. 补肾益气化瘀解毒汤与氨基葡萄糖胶囊治疗骨关节炎疗效观察[J]. 陕西中医,2014,35(12):1628-1629.
[34] DONSANTE S, PALMISANO B, SERAFINI M, et al. From stem cells to bone-forming cells. Int J Mol Sci. 2021;22(8):3989-4011.
[35] MARINI F, GIUSTI F, PALMINI G, et al. Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders. Osteoporos Int. 2023;34(2):213-238.
[36] KO FC, SUMNER DR. How faithfully does intramembranous bone regeneration recapitulate embryonic skeletal development? Dev Dyn. 2021;250(3):377-392.
[37] BAI Y, ZHANG Q, CHEN Q, et al. Conditional knockout of the PDK-1 gene in osteoblasts affects osteoblast differentiation and bone formation. J Cell Physiol. 2021;236(7):5432-5445.
[38] XU J, FU L, BAI J, et al. Low-dose IL-34 has no effect on osteoclastogenesis but promotes osteogenesis of hBMSCs partly via activation of the PI3K/AKT and ERK signaling pathways. Stem Cell Res Ther. 2021;12(1):268-283.
[39] WANG G, WAN L, ZHANG L, et al. MicroRNA-133a regulates the viability and differentiation fate of bone marrow mesenchymal stem cells via MAPK/ERK signaling pathway by targeting FGFR1. DNA Cell Biol. 2021;40(8):1112-1123.
[40] WANG Z, LIU Q, LIU C, et al. Mg2+ in β-TCP/Mg-Zn composite enhances the differentiation of human bone marrow stromal cells into osteoblasts through MAPK-regulated Runx2/Osx. J Cell Physiol. 2020;235(6):5182-5191. |